Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Demyelinating Autoimmune Diseases, CNS”

3,686 trials

Showing 20 of 3,686 results

Not applicableStudy completedNCT03302442
What this trial is testing

Comparison of Oral Molecules Preventing Relapses in Multiple Sclerosis

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Nantes University Hospital 3,000
Large-scale testing (Phase 3)Study completedNCT06987851
What this trial is testing

An Extension Clinical Study of the Efficacy and Safety of BCD-132 in Patients With Multiple Sclerosis Who Previously Received Therapy in Clinical Studies of JSC BIOCAD

Who this might be right for
Multiple Sclerosis
Biocad 44
Not applicableStudy completedNCT05746845
What this trial is testing

Implication of 5-HT7 Receptor in Inflammatory Mechanisms in Multiple Sclerosis

Who this might be right for
HealthyMultiple Sclerosis
Centre Hospitalier Régional d'Orléans 100
Large-scale testing (Phase 3)Study completedNCT01874145
What this trial is testing

Safety and Tolerability of Glatiramer Acetate

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 209
Not applicableActive Not RecruitingNCT07028879
What this trial is testing

Effectiveness of a One-year Group Program for Fatigue Management in Minimally Impaired People With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Hospital Clinic of Barcelona 24
Not applicableStudy completedNCT03244696
What this trial is testing

Behavior and Activity Monitoring in MS

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Ohio State University 87
Not applicableStudy completedNCT00617383
What this trial is testing

AT RISK FOR MS - Clinical Conversion of Female Monozygotic Twins Discordant for CIS/MS

Who this might be right for
Multiple SclerosisClinically Isolated Syndrome
The University of Texas Health Science Center, Houston 3
Early research (Phase 1)Study completedNCT02583594
What this trial is testing

Characterize Subcutaneous or Intravenous Alemtuzumab in Patients With Progressive Multiple Sclerosis

Who this might be right for
Progressive Multiple Sclerosis
Genzyme, a Sanofi Company 24
Testing effectiveness (Phase 2)Study completedNCT01071083
What this trial is testing

Treatment Interruption of Natalizumab

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Biogen 175
Large-scale testing (Phase 3)Active Not RecruitingNCT05346354
What this trial is testing

Efficacy and Safety Study of Ravulizumab IV in Pediatric Participants With NMOSD

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Alexion Pharmaceuticals, Inc. 12
Not applicableLooking for participantsNCT07168772
What this trial is testing

The Effect of a Probiotic Administration as an add-on Treatment in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Hospital Universitari Vall d'Hebron Research Institute 80
Not applicableUnknownNCT06068829
What this trial is testing

Inebilizumab and Rituximab in Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis Optica Spectrum Disorders
Feng Jinzhou 80
Not applicableUnknownNCT03817073
What this trial is testing

Assessing Fatiguability of Tongue Muscles in MS

Who this might be right for
Muscle WeaknessFatigueMultiple Sclerosis+2 more
Thomas More Kempen 60
Not applicableEnded earlyNCT01380041
What this trial is testing

Cytokine in Cerebrospinal Fluid (CSF) From Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis
University Hospital, Montpellier 101
Not applicableUnknownNCT02352194
What this trial is testing

Physical Capacity and Rehabilitation of Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS)
Assistance Publique - Hôpitaux de Paris 60
Post-approval studies (Phase 4)Study completedNCT00785473
What this trial is testing

Can Vitamin D Supplementation Prevent Bone Loss in Persons With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Osteoporosis
University Hospital of North Norway 80
Early research (Phase 1)Study completedNCT02618902
What this trial is testing

A "negative"dendritic Cell-based Vaccine for the Treatment of Multiple Sclerosis: a First-in-human Clinical Trial

Who this might be right for
Multiple Sclerosis
University Hospital, Antwerp 9
Not applicableUnknownNCT03444454
What this trial is testing

Telerehabilitation in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Fondazione Don Carlo Gnocchi ETS 136
Not applicableStudy completedNCT05334472
What this trial is testing

A Survey to Evaluate Early Experience From Patient and Care Partner on Injection and Device for KESIMPTA® Indicated for Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Novartis Pharmaceuticals 105
Testing effectiveness (Phase 2)Study completedNCT03740295
What this trial is testing

Impact of Ketone Bodies and Epigallocatechin Gallate in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Fundación Universidad Católica de Valencia San Vicente Mártir 60
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation